Endo International
Based in PA
🤖
AI Overview
With $3.3M in lobbying spend across 24 quarterly filings, Endo International is a significant lobbying presence. Their lobbying covers 1 issue area. Active from 2018 to 2023.
$3.3M
Total Spend
6
Years Active
1
Firms Hired
1
Lobbyists Deployed
1
Issues Lobbied
Spending Trend
View as table
| Year | Lobbying Spend |
|---|---|
| 2018 | $450K |
| 2019 | $560K |
| 2020 | $560K |
| 2021 | $560K |
| 2022 | $700K |
| 2023 | $420K |
Issues Lobbied
Lobbying Firms
Lobbyists
What They Lobby About
These are actual descriptions from their quarterly lobbying disclosure filings, summarizing what they lobbied Congress and federal agencies about.Issue areas: Medicare/Medicaid
- •Issues related to Medicare reimbursement of pharmaceuticals and the Inflation Reduction Act; Issues related to FDA policy; Issues related to implementation of the Bipartisan Infrastructure Law
- •Issues relating to rulemaking around Single-use Package Drugs; Issues related to implementation of the Inflation Reduction Act and the Bipartisan Infrastructure Bill
Related Analysis
Related Investigations
Similar Clients
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.